1-4 of 4
Mark Danese, MHS, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Societal Costs of Sickle Cell Disease in the United States

Irene Agodoa, MD, Deborah Lubeck, PhD, Nickhill Bhakta, MD MPH, Mark Danese, MHS, PhD, Kartik Pappu, PhD, Robin Howard, MBA, Michelle Gleeson, PhD, Marc Halperin, BA, Sophie Lanzkron, MD MHS
Journal: Blood
Blood (2018) 132 (Supplement 1): 4706.
https://doi.org/10.1182/blood-2018-99-119420
Published: 2018
Journal Articles

Systematic Literature Review of the Global Incidence and Prevalence of Myelodysplastic Syndrome and Acute Myeloid Leukemia

Deborah P Lubeck, PhD, Mark Danese, MHS, PhD, Duryea Jennifer, MPH, Kimberly Miller, PhD, Akshara Richhariya, PhD, Phillip M. Garfin, MD PhD
Journal: Blood
Blood (2016) 128 (22): 5930.
https://doi.org/10.1182/blood.V128.22.5930.5930
Published: 2016
Journal Articles

Patterns of Chemotherapy/Immunotherapy and Survival in Mantle Cell Lymphoma: Evidence from SEER-Medicare

Robert Griffiths, ScD, Mark Danese, MHS, PhD, Michelle Gleeson, PhD, Kevin Knopf, MD
Journal: Blood
Blood (2008) 112 (11): 5293.
https://doi.org/10.1182/blood.V112.11.5293.5293
Published: 2008
Journal Articles

Validating the Follicular Lymphoma International Prognostic Index (FLIPI) Using SEER-Medicare Claims Data

Mark Danese, MHS, PhD, Robert Griffiths, ScD, Michelle Gleeson, PhD, Kevin Knopf, MD
Journal: Blood
Blood (2008) 112 (11): 872.
https://doi.org/10.1182/blood.V112.11.872.872
Published: 2008